108 results on '"Hyman, B"'
Search Results
2. A Phase I Trial of Alpelisib Combined With Capecitabine in Patients With HER2-Negative Metastatic Breast Cancer
3. Palbociclib in adults aged 70 years and older with advanced breast cancer: A phase 2 multicenter trial (Alliance A171601)
4. Geriatric assessment-guided interventions for older adults with multiple myeloma: A feasibility and acceptability study
5. Emergency department visits and hospitalizations in older women treated for early stage breast cancer
6. Prevalence and clinical correlates of cognitive impairment in adults with plasma cell disorders
7. Age and competing concerns in treatment selection for women with non-metastatic HR+ and HER2- breast cancer: Current clinical practice
8. Geriatric-assessment-identified functional deficits among adults with multiple myeloma with normal performance status
9. Exercise-induced modulation of monocytes in breast cancer survivors
10. Association between a cognitive screening test and severe chemotherapy toxicity in older adults with cancer
11. Arti Hurria, M.D.: A tribute to her shining legacy in the Alliance for Clinical Trials in Oncology
12. Inflammatory markers and overall survival in older adults with cancer
13. Clinician-observed and patient-reported toxicities and their association with poor tolerance to therapy in older patients with head and neck or lung cancer treated with curative radiotherapy
14. Frequency and impact of grade three or four toxicities of novel agents on outcomes of older patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma (alliance A151611)
15. The incremental value of a geriatric assessment-derived three-item scale on estimating overall survival in older adults with cancer
16. Time-to-Treatment-Failure and Related Outcomes Among 1000+ Advanced Non–Small Cell Lung Cancer Patients: Comparisons Between Older Versus Younger Patients (Alliance A151711)
17. The preference to receive chemotherapy and cancer-related outcomes in older adults with breast cancer CALGB 49907 (Alliance)
18. The impact of actual body weight-based chemotherapy dosing and body size on adverse events and outcome in older patients with breast cancer: Results from Cancer and Leukemia Group B (CALGB) trial 49907 (Alliance A151436)
19. Frailty and skeletal muscle in older adults with cancer
20. Activities, function, and health-related quality of life (HRQOL) of older adults with cancer
21. Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review
22. Comparison of efficacy of immune checkpoint inhibitors (ICIs) between younger and older patients: A systematic review and meta-analysis
23. Healthcare satisfaction in older and younger patients with cancer
24. Prognostic value of lymphocyte-to-monocyte ratio in patients with solid tumors: A systematic review and meta-analysis
25. A randomized controlled trial of outpatient CAncer REhabilitation for older adults: The CARE Program
26. The prevalence of potentially modifiable functional deficits and the subsequent use of occupational and physical therapy by older adults with cancer
27. Self-directed physical activity intervention in older adults undergoing adjuvant chemotherapy for colorectal cancer: Design of a randomized controlled trial
28. Feasibility of geriatric assessment in community oncology clinics
29. Feasibility and promise of a 6-week program to encourage physical activity and reduce joint symptoms among elderly breast cancer survivors on aromatase inhibitor therapy
30. Effects of adjuvant exemestane versus anastrozole on bone mineral density for women with early breast cancer (MA.27B): a companion analysis of a randomised controlled trial
31. Managing metastatic human epidermal growth factor receptor 2 (HER2)-positive breast cancer in the older patient
32. A planned, prospective comparison of short-term quality of life outcomes among older patients with breast cancer treated with standard chemotherapy in a randomized clinical trial vs. an observational study: CALGB #49907 and #369901
33. Challenges in the Treatment of Older Breast Cancer Patients
34. Discrepancy Between Preference and Actual Adjuvant Therapy for Breast Cancer
35. Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial
36. A Question of Duration: Do Patients with Early-Stage Breast Cancer Need More Than Five Years of Adjuvant Endocrine Therapy?
37. Association of p16, a Biomarker of Cellular Senescence, with Receipt of Therapy for Plasma Cell Disorders
38. Extended Adjuvant Endocrine Therapy in Breast Cancer: Current Status and Future Directions
39. Geriatric assessment for oncologists: Rationale and future directions
40. Mental status evaluation in older adults with cancer: Development of the Mental Health Index-13
41. Modulation of Agonist Binding to Human Dopamine Receptor Subtypes by l-Prolyl-l-leucyl-glycinamide and a Peptidomimetic Analog
42. "...Paying to be a Patient in the Hospital and the Parking Lot": Dyadic Perspectives on Multiple Myeloma-Related Healthcare Access Barriers
43. Delineation of the conserved functional properties of D 1A, D 1B and D 1C dopamine receptor subtypes in vertebrates
44. Breast cancer in older patients
45. Introduction: cancer in the elderly
46. Optimizing the Use of Anthracyclines in the Adjuvant Treatment of Early-Stage Breast Cancer
47. Mutations in the lipid-binding domain of α-synuclein confer overlapping, yet distinct, functional properties in the regulation of dopamine transporter activity
48. Neonatal neuronal overexpression of glycogen synthase kinase-3β reduces brain size in transgenic mice
49. Dual Regulation of NMDA Receptor Functions by Direct Protein-Protein Interactions with the Dopamine D1 Receptor
50. A Cross-Sectional Analysis of County-Level Social Vulnerability and Physical Frailty Among Adults with Hematological Malignancies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.